Rare Disease Programs
“New therapies are critically needed, and I look forward to Dimension’s progress in advancing its gene therapy program into the clinic.”
David A. Weinstein, MD, MMSc, Professor, Director of the Glycogen Storage Disease Program, University of Florida College of Medicine